Search Results - "Lopez Bernal, Jamie"
-
1
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
Published in Nature medicine (01-04-2022)“…Booster vaccination with messenger RNA (mRNA) vaccines has been offered to adults in England starting on 14 September 2021. We used a test-negative…”
Get full text
Journal Article -
2
SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England
Published in The Lancet infectious diseases (01-03-2021)“…Understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and transmission in educational settings is crucial for ensuring the…”
Get full text
Journal Article -
3
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Published in BMJ (Online) (13-05-2021)“…To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms…”
Get more information
Journal Article -
4
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
Published in The Lancet infectious diseases (01-09-2020)“…There are few primary care studies of the COVID-19 pandemic. We aimed to identify demographic and clinical risk factors for testing positive for severe acute…”
Get full text
Journal Article -
5
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Published in The New England journal of medicine (12-08-2021)“…The B.1.617.2 (delta) Covid-19 variant has surged in India and spread worldwide. In a test-negative case–control study, the effectiveness of two doses of…”
Get full text
Journal Article -
6
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Published in The Lancet (British edition) (02-04-2022)“…The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity…”
Get full text
Journal Article -
7
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Published in The New England journal of medicine (27-01-2022)“…A test-negative case–control study involving more than 6 million persons in England who received two doses of the ChAdOx1-S or BNT162b2 vaccine (interval, 3 to…”
Get full text
Journal Article -
8
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Published in The Lancet infectious diseases (01-11-2021)“…The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first…”
Get full text
Journal Article -
9
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study
Published in The Lancet infectious diseases (01-11-2023)“…Bivalent BA.1 booster vaccines were offered to adults aged 50 years or older and clinically vulnerable people as part of the 2022 autumn COVID-19 booster…”
Get full text
Journal Article -
10
Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design
Published in International journal of epidemiology (03-05-2021)“…Abstract Background The impact of SARS-CoV-2 alongside influenza is a major concern in the northern hemisphere as winter approaches. Methods Test data for…”
Get full text
Journal Article -
11
Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
Published in Nature communications (12-12-2022)“…Despite the availability of the ChAdOx1-S booster vaccine, little is known about the real-world effectiveness although clinical trials have demonstrated…”
Get full text
Journal Article -
12
COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England
Published in BJOG : an international journal of obstetrics and gynaecology (01-12-2024)“…ABSTRACT Objective Assessment of COVID‐19 vaccine safety in pregnancy using population‐based data. Design Matched case–control study nested in a retrospective…”
Get full text
Journal Article -
13
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages
Published in The Journal of infectious diseases (13-09-2022)“…Abstract To investigate if the AY.4.2 sublineage of the SARS-CoV-2 delta variant is associated with hospitalization and mortality risks that differ from…”
Get full text
Journal Article -
14
Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (14-04-2022)“…BackgroundHouseholds appear to be the highest risk setting for COVID-19 transmission. Large household transmission studies in the early stages of the pandemic…”
Get full text
Journal Article -
15
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England
Published in JMIR public health and surveillance (02-04-2020)“…The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) have successfully worked together on…”
Get full text
Journal Article -
16
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
Published in Influenza and other respiratory viruses (01-05-2024)“…ABSTRACT Background We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital…”
Get full text
Journal Article -
17
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (13-08-2020)“…Severe acute respiratory syndrome coronavirus 2 viral load in the upper respiratory tract peaks around symptom onset and infectious virus persists for 10 days…”
Get full text
Journal Article -
18
The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms
Published in JMIR public health and surveillance (02-07-2020)“…Routinely recorded primary care data have been used for many years by sentinel networks for surveillance. More recently, real world data have been used for a…”
Get full text
Journal Article -
19
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply
Published in The New England journal of medicine (16-12-2021)Get full text
Journal Article -
20
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
Published in Nature communications (30-09-2022)“…The Omicron variant has been associated with reduced vaccine effectiveness (VE) against mild disease with rapid waning. Meanwhile Omicron has also been…”
Get full text
Journal Article